CD4+ | CD8+ | |||||
---|---|---|---|---|---|---|
Age | Immunization | CD44hi CD62L** | CD44hi CD62L** | |||
in mice | in human equivarent* | with BCG& | low (TEM) | high (TCM) | low (TEM) | high (TCM) |
30-week | late 10's | + | 72.2 ± 0.82 | 15.6 ± 0.80 | 61.7 ± 0.03 | 14.7 ± 0.49 |
- | 74.5 ± 1.23 | 13.8 ± 0.35 | 48.2 ± 7.95 | 14.0 ± 3.67 | ||
81-90-week | late 50's | + | 85.75 ± 5.91 | 2.85 ± 0.67 | 87.51 ± 6.94 | 2.07 ± 0.12 |
- | 93.03 ± 0.56 | 5.95 ± 0.68 | 95.90 ± 0.82 | 3.38 ± 1.94 | ||
Boosting with Oligo-B | ||||||
30-week | late 10's | + | 73.6 ± 1.92 | 17.3 ± 0.32 | 53.7 ± 10.3 | 9.95 ± 0.15 |
- | 78.1 ± 3.89 | 14.6 ± 0.88 | 51.8 ± 0.48 | 10.2 ± 0.11 | ||
81-90-week | late 50's | + | 89.12 ± 0.62 | 7.76 ± 3.26 | 95.29 ± 0.82 | 2.66 ± 1.08 |
- | 85.82 ± 0.01 | 3.82 ± 0.42 | 92.07 ± 1.41 | 3.98 ± 0.12 |